We’re increasing our Eli Lilly price target after another beat-and-raise quarter
Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…
We’re adding to our position in a chipmaker as the AI trade regains its footing
Shortly after the opening bell, we will buy 100 shares of Intel at roughly $97.97. Following the trade,…
SpaceX dives 10% after AI spending surge rattles investors
A live feed shows SpaceX CEO Elon Musk on the day of SpaceX’s initial public offering (IPO) at…
SoftBank shares: Asian tech rally, SK Hynix, Samsung, Advantest
CANADA – 2025/08/07: In this photo illustration, the SoftBank Group (Soft Bank) logo is seen displayed on a…
Big Tech’s Anthropic and OpenAI stakes distort corporate earnings
India Prime Minister Narendra Modi, left, with OpenAI CEO Sam Altman, center, and Anthropic CEO Dario Amodei at…
Visa to buy fraud-detection firm BioCatch for $2.4 billion
Nikolas Kokovlis | Nurphoto | Getty Images Visa on Monday said it is acquiring fraud detection startup BioCatch…
Kalshi traders think July jobs will come in cooler than estimates
A Contemporary Services Corporation (CSC) now hiring flyer is displayed for job opportunities as an event security guard…
Alibaba shares rally after unveiling Qwen3.8-Max AI model
Alibaba debuts Qwen3-Max, its trillion-parameter AI model trained on 36T tokens. (Photo by Nikolas Kokovlis/NurPhoto via Getty Images)…
Leopold Aschenbrenner Situational Awareness fund: $45B to fire sale
Leopold Aschenbrenner Photo: Josh Edelson Two years ago, Leopold Aschenbrenner argued he was one of few people in…
Novo Nordisk shares fall after heart medicine trial results
Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart…
SK Hynix, Samsung stocks: AI rally roars back
Omar Marques | Lightrocket | Getty Images South Korea’s chip heavyweights SK Hynix and Samsung Electronics skyrocketed in…
FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business
The boom in GLP-1 weight-loss drugs and other specialized medicines has created lucrative logistics opportunities in an industry…